Ulcerative Colitis/Crohn’s Disease Study

Join the
AVIATOR Study today

A Clinical Research Study for Children and Teens with Ulcerative Colitis or Crohn’s Disease

Start Screening Now

About the Study

The AVIATOR Study is evaluating an investigational drug for children and teens (ages 2-17) with moderately to severely active Ulcerative Colitis (UC) or Crohn’s Disease (CD). If your child has been struggling with moderate to severe symptoms and has not responded to other treatments, this study may be an option.

What is Ulcerative Colitis & Crohn's Disease?
UC and CD are types of inflammatory bowel disease (IBD) that affect the gastrointestinal tract, causing symptoms such as pain, bleeding, and digestive issues. Finding effective treatments is critical to improving the lives of those who suffer from these conditions.

Study Details:

Participants will receive an investigational study drug through an IV at three study visits.
Depending on their response, participants may be switched to a subcutaneous injection for the remainder of the study.
The study lasts up to 57 weeks, including 18 study visits.
Parents will track their child’s symptoms via an electronic diary.

Why Participate?

Access to new healthcare options and study drugs at no cost.

Travel compensation and study-related care.

Contributing to advancing medical research.

Who Can Participate?

Your child might be eligible if they:

Aged 2 - 17 years

Have been diagnosed with UC or CD for at least 1 month

Currently experiencing moderate to severe symptoms

Tried at least one other treatment that didn't work

Click below to fill out the screener form and determine if your child qualifies.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Join the AVIATOR Study today